Brief: Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Update
13/05/2025 21:11
May 13 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A: LINEAGE CELL THERAPEUTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE LINEAGE CELL THERAPEUTICS INC: CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES EXPECTED TO SUPPORT PLANNED OPERATIONS INTO Q1 2027 Source text: ID:nBw376q0fa Further company coverage: LCTX.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million